---
figid: PMC9025131__marinedrugs-20-00258-g006
pmcid: PMC9025131
image_filename: marinedrugs-20-00258-g006.jpg
figure_link: /pmc/articles/PMC9025131/figure/marinedrugs-20-00258-f006/
number: Figure 6
figure_title: ''
caption: Fucoidan regulated GSK3β-Nrf2-HO-1 signaling pathway in hippocampus and kidney
  of adenine-induced CKD mice (n = 8). (A–D) The mRNA expression of GSK3β, Nrf2, HO-1,
  and NQO-1 in the hippocampus. (E–H) The mRNA expression of GSK3β, Nrf2, HO-1, and
  NQO-1 in the kidney. * p < 0.05, ** p < 0.01, and *** p < 0.001 vs. vehicle group
  (Veh), one-way ANOVA post hoc Dunnett’s test.
article_title: The Emerging Evidence for a Protective Role of Fucoidan from Laminaria
  japonica in Chronic Kidney Disease-Triggered Cognitive Dysfunction.
citation: Zhihui Ma, et al. Mar Drugs. 2022 Apr;20(4):258.
year: '2022'

doi: 10.3390/md20040258
journal_title: Marine Drugs
journal_nlm_ta: Mar Drugs
publisher_name: MDPI

keywords:
- chronic kidney disease
- fucoidan
- cognitive dysfunction
- neuroinflammation
- oxidative stress
- GSK3β-Nrf2-HO-1 signaling
- microglial polarization

---
